These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 26788788)

  • 21. Effect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double-blind, placebo-controlled trial.
    O'Brien JM; Defranco EA; Adair CD; Lewis DF; Hall DR; How H; Bsharat M; Creasy GW;
    Ultrasound Obstet Gynecol; 2009 Dec; 34(6):653-9. PubMed ID: 19918965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What we have learned about the role of 17-alpha-hydroxyprogesterone caproate in the prevention of preterm birth.
    Caritis SN; Feghali MN; Grobman WA; Rouse DJ;
    Semin Perinatol; 2016 Aug; 40(5):273-80. PubMed ID: 27105940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Is universal screening for cervical length among singleton pregnancies with no history of preterm birth justified?].
    Rozenberg P
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1337-1345. PubMed ID: 28166925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevention of preterm birth with vaginal progesterone in women with preterm labor: which are the evidences?].
    Martinez de Tejada B; Othenin-Girard V; Irion O
    Rev Med Suisse; 2015 Oct; 11(492):2004, 2006-8, 2010. PubMed ID: 26672179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaginal progesterone, cerclage or cervical pessary for preventing preterm birth in asymptomatic singleton pregnant women with a history of preterm birth and a sonographic short cervix.
    Alfirevic Z; Owen J; Carreras Moratonas E; Sharp AN; Szychowski JM; Goya M
    Ultrasound Obstet Gynecol; 2013 Feb; 41(2):146-51. PubMed ID: 22991337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [What use of progesterone to prevent preterm birth?].
    Legardeur H; Mandelbrot L; Kayem G
    Gynecol Obstet Fertil; 2013; 41(7-8):459-64. PubMed ID: 23876420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregnancy duration with use of 17-α-hydroxyprogesterone caproate in a retrospective cohort at high risk of recurrent preterm birth.
    Massa K; Childress K; Vricella LK; Boerrigter A; Franklin BHK; Sauer M; Armbruster R; Tomlinson T
    Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100219. PubMed ID: 33345927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaginal progesterone, but not 17α-hydroxyprogesterone caproate, has antiinflammatory effects at the murine maternal-fetal interface.
    Furcron AE; Romero R; Plazyo O; Unkel R; Xu Y; Hassan SS; Chaemsaithong P; Mahajan A; Gomez-Lopez N
    Am J Obstet Gynecol; 2015 Dec; 213(6):846.e1-846.e19. PubMed ID: 26264823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 17-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study.
    Nelson DB; McIntire DD; McDonald J; Gard J; Turrichi P; Leveno KJ
    Am J Obstet Gynecol; 2017 Jun; 216(6):600.e1-600.e9. PubMed ID: 28223163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progesterone and preterm birth.
    Norman JE
    Int J Gynaecol Obstet; 2020 Jul; 150(1):24-30. PubMed ID: 32524598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The safety of progestogen in the prevention of preterm birth: meta-analysis of neonatal mortality.
    Ahn KH; Bae NY; Hong SC; Lee JS; Lee EH; Jee HJ; Cho GJ; Oh MJ; Kim HJ
    J Perinat Med; 2017 Jan; 45(1):11-20. PubMed ID: 27124668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.
    DeFranco EA; O'Brien JM; Adair CD; Lewis DF; Hall DR; Fusey S; Soma-Pillay P; Porter K; How H; Schakis R; Eller D; Trivedi Y; Vanburen G; Khandelwal M; Trofatter K; Vidyadhari D; Vijayaraghavan J; Weeks J; Dattel B; Newton E; Chazotte C; Valenzuela G; Calda P; Bsharat M; Creasy GW
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):697-705. PubMed ID: 17899571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of transvaginal ultrasound cervical length screening in singletons without a prior preterm birth: an update.
    Werner EF; Hamel MS; Orzechowski K; Berghella V; Thung SF
    Am J Obstet Gynecol; 2015 Oct; 213(4):554.e1-6. PubMed ID: 26071914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 17-alpha hydroxyprogesterone caproate for preterm birth prevention: Where have we been, how did we get here, and where are we going?
    Manuck TA
    Semin Perinatol; 2017 Dec; 41(8):461-467. PubMed ID: 28947068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The use of progestatives for the prevention of spontaneous preterm birth].
    Azria E
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1280-1298. PubMed ID: 27776845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Progesterone for Prevention of Preterm Birth--Evidence-based Indications].
    Kuon RJ; Abele H; Berger R; Garnier Y; Maul H; Schleußner E; Rath W;
    Z Geburtshilfe Neonatol; 2015 Jun; 219(3):125-35. PubMed ID: 26114408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimated effect of 17 alpha-hydroxyprogesterone caproate on preterm birth in the United States.
    Petrini JR; Callaghan WM; Klebanoff M; Green NS; Lackritz EM; Howse JL; Schwarz RH; Damus K
    Obstet Gynecol; 2005 Feb; 105(2):267-72. PubMed ID: 15684150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re-analysis of the PREGNANT trial confirms that vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix.
    McKay LA; Holford TR; Bracken MB
    Ultrasound Obstet Gynecol; 2014 May; 43(5):596-7. PubMed ID: 24585456
    [No Abstract]   [Full Text] [Related]  

  • 39. Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double-blind multicentre trial.
    Serra V; Perales A; Meseguer J; Parrilla JJ; Lara C; Bellver J; Grifol R; Alcover I; Sala M; Martínez-Escoriza JC; Pellicer A
    BJOG; 2013 Jan; 120(1):50-7. PubMed ID: 22882759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [PREVENTION OF PRETERM BIRTH IN TWINS WITH SHORT MID-TRIMESTER CERVICAL LENGTH LESS THAN 25MM -COMBINED TREATMENT WITH ARABIN'S CERCLAGE PESSARY AND INTRAVAGINAL MICRONIZED PROGESTERONE COMPARED WITH CONSERVATIVE TREATMENT].
    Zimerman A; Maymon R; Viner Y; Glick N; Herman A; Neeman O
    Harefuah; 2018 May; 157(5):301-304. PubMed ID: 29804334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.